Morgan Stanley’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$170K Sell
11,350
-797
-7% -$11.7K ﹤0.01% 5942
2025
Q4
$162K Sell
12,147
-3,030
-20% -$44.3K ﹤0.01% 6008
2025
Q3
$239K Sell
15,177
-2,412
-14% -$39.7K ﹤0.01% 5819
2025
Q2
$265K Sell
17,589
-2,607
-13% -$38.1K ﹤0.01% 5738
2025
Q1
$304K Sell
20,196
-6,315
-24% -$93.4K ﹤0.01% 5553
2024
Q4
$382K Sell
26,511
-70,280
-73% -$1.26M ﹤0.01% 5534
2024
Q3
$1.89M Buy
96,791
+12,954
+15% +$234K ﹤0.01% 4691
2024
Q2
$1.44M Buy
83,837
+50,521
+152% +$932K ﹤0.01% 4769
2024
Q1
$560K Sell
33,316
-42,408
-56% -$643K ﹤0.01% 5264
2023
Q4
$1.37M Buy
75,724
+29,546
+64% +$537K ﹤0.01% 5149
2023
Q3
$782K Buy
46,178
+2,752
+6% +$39.4K ﹤0.01% 4937
2023
Q2
$521K Sell
43,426
-29,380
-40% -$401K ﹤0.01% 5190
2023
Q1
$948K Sell
72,806
-73,187
-50% -$1.2M ﹤0.01% 4893
2022
Q4
$2.16M Sell
145,993
-99,607
-41% -$1.09M ﹤0.01% 4415
2022
Q3
$2.17M Buy
245,600
+11,568
+5% +$146K ﹤0.01% 4369
2022
Q2
$2.96M Buy
234,032
+46,997
+25% +$598K ﹤0.01% 4226
2022
Q1
$3.54M Buy
187,035
+7,091
+4% +$181K ﹤0.01% 4042
2021
Q4
$6.31M Sell
179,944
-76,680
-30% -$2.49M ﹤0.01% 3467
2021
Q3
$9.39M Buy
256,624
+56,445
+28% +$2.22M ﹤0.01% 2965
2021
Q2
$7.86M Sell
200,179
-21,888
-10% -$632K ﹤0.01% 3274
2021
Q1
$6.27M Sell
222,067
-47,949
-18% -$1.53M ﹤0.01% 3173
2020
Q4
$8.65M Buy
270,016
+183,672
+213% +$5.65M ﹤0.01% 2668
2020
Q3
$2.79M Buy
86,344
+30,827
+56% +$961K ﹤0.01% 3339
2020
Q2
$1.53M Sell
55,517
-50,257
-48% -$1.09M ﹤0.01% 3835
2020
Q1
$1.89M Sell
105,774
-23,967
-18% -$578K ﹤0.01% 3417
2019
Q4
$3.25M Buy
129,741
+102,597
+378% +$2.25M ﹤0.01% 3639
2019
Q3
$484K Buy
27,144
+3,156
+13% +$65.7K ﹤0.01% 4694
2019
Q2
$528K Sell
23,988
-17,504
-42% -$500K ﹤0.01% 4583
2019
Q1
$1.27M Sell
41,492
-10,607
-20% -$265K ﹤0.01% 3951
2018
Q4
$1.2M Buy
52,099
+48,873
+1,515% +$1.52M ﹤0.01% 4145
2018
Q3
$104K Sell
3,226
-14,623
-82% -$446K ﹤0.01% 5670
2018
Q2
$538K Buy
17,849
+6,520
+58% +$207K ﹤0.01% 5050
2018
Q1
$334K Buy
11,329
+11,197
+8,483% +$398K ﹤0.01% 5225
2017
Q4
$5K Sell
132
-6,165
-98% -$197K ﹤0.01% 6334
2017
Q3
$171K Sell
6,297
-668
-10% -$16.4K ﹤0.01% 5416
2017
Q2
$163K Buy
6,965
+6,818
+4,638% +$140K ﹤0.01% 5440
2017
Q1
$3K Buy
+147
New +$2.21K ﹤0.01% 6419
2016
Q4
Sell
-35,349
Closed -$421K 6537
2016
Q3
$421K Buy
+35,349
New +$452K ﹤0.01% 4625
2016
Q2
Sell
-11
Closed 6563
2016
Q1
$0 Buy
+11
New +$147 ﹤0.01% 6632

Other funds holding HCM

Morgan Stanley's HCM Position: Q1 2026 in Review

Morgan Stanley reduced its HUTCHMED (HCM) stake by 6.6% in Q1 2026, selling an estimated $11.7K and leaving 11,350 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #5942.

Morgan Stanley first reported a position in HCM in Q1 2016 and has held it in 39 quarters since. The position peaked at $9.39M in Q3 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Morgan Stanley held 11,350 shares of HUTCHMED worth $170K as of Q1 2026.
  • Morgan Stanley sold 797 HUTCHMED shares in Q1 2026, an estimated $11.7K.
  • HUTCHMED made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5942 holding.
  • Morgan Stanley first reported a position in HUTCHMED in Q1 2016 and has held it in 39 quarters since.
  • Morgan Stanley's HUTCHMED position peaked at $9.39M in Q3 2021.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.